Fetal DNA Test (Non-Invasive Prenatal Testing – NIPT)

The Fetal DNA test is a screening test performed by analyzing fetal genetic material (fetal DNA) circulating in the mother’s blood. Throughout pregnancy, fetal cells enter the maternal bloodstream, and the fetal DNA contained within these cells is isolated and analyzed using advanced laboratory techniques. This test is primarily used to screen for chromosomal abnormalities such as Down syndrome (Trisomy 21), Trisomy 18, and Trisomy 13. Since it is a non-invasive method, the Fetal DNA test carries significantly less risk compared to traditional invasive procedures such as amniocentesis and has a high accuracy rate.

How Is the Fetal DNA Test Performed?

The Fetal DNA test can be performed starting from the 10th week of pregnancy. It is carried out using a blood sample taken from the expectant mother. The blood sample is sent to a laboratory, where cell-free fetal DNA (cffDNA) is isolated. This isolated DNA is then analyzed to assess the chromosomal structure of the fetus. Test results are usually available within 1–2 weeks and indicate whether there are abnormalities in specific chromosomes.

When Is the Fetal DNA Test Recommended?

The Fetal DNA test is especially recommended for pregnancies in the high-risk group. It may be advised in the following situations:

Advanced maternal age: Pregnancies in women aged 35 and older, as the risk of chromosomal abnormalities increases with age.

Positive screening test results: When first-trimester, triple, or quadruple screening tests indicate a high risk of aneuploidy.

Family history of genetic abnormalities: Expectant mothers with a previous history of a baby affected by trisomy may be advised to undergo the Fetal DNA test.

Ultrasound findings: Certain abnormalities detected on fetal ultrasound can be further evaluated using the Fetal DNA test.

Rh incompatibility: If the mother is Rh-negative and the father is Rh-positive, and there is a risk of blood incompatibility in the fetus, the Fetal DNA test may be recommended.

What Are the Advantages of the Fetal DNA Test?

Compared to other screening and diagnostic methods, the Fetal DNA test offers several advantages:

Non-Invasive Method: Since it is performed using maternal blood, it carries much less risk than invasive procedures such as amniocentesis or chorionic villus sampling (CVS).

High Accuracy: The Fetal DNA test has an accuracy rate of over 99% in detecting chromosomal abnormalities such as Down syndrome.

Early Testing: It can be performed as early as the 10th week of pregnancy, providing reliable information at an early stage.

Rapid Results: Test results are usually available within 1–2 weeks.

What Are the Limitations of the Fetal DNA Test?

Although the Fetal DNA test is a highly reliable screening method, it does have certain limitations:

Not 100% Diagnostic: The Fetal DNA test is a screening test and does not provide definitive diagnosis. If results are positive, confirmatory invasive diagnostic tests such as amniocentesis may be required.

Fetal DNA Fraction: Test accuracy depends on having a sufficient amount of fetal DNA in the maternal bloodstream. If this fraction is below 4%, results may be unreliable.

Limited Chromosomal Scope: The test screens for specific chromosomal abnormalities only. Other genetic disorders may require different diagnostic tests.

The Fetal DNA test is increasingly used as a reliable and non-invasive method for aneuploidy screening during pregnancy. Due to its high accuracy and early applicability, it has become a preferred screening option, especially for high-risk pregnancies. However, it is important to understand its limitations and to evaluate the results in detail with your physician. While the Fetal DNA test does not provide a definitive diagnosis, it serves as a highly valuable screening tool, and further diagnostic testing may be recommended if necessary.